Note: Ingredients listed on restricted chemical lists
EC/CAS
107-21-1
Name of the chemical
Ethane-1,2-diol
Concentration
10-30
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
10-30
EC/CAS
111-46-6
Name of the chemical
diethyleneglycol
Concentration
7-13 5-10
EC/CAS
68412-54-4
Name of the chemical
Nonylphenolethoxylates (NPEO)
Concentration
3-7
EC/CAS
1333-86-4
Name of the chemical
carbon black
Concentration
3-7 1-5
EC/CAS
126-73-8
Name of the chemical
Tributyl phosphate
Concentration
1-5
EC/CAS
1317-70-0
Name of the chemical
Titanium dioxide in powder form containing 1 % or more of particles with aerodynamic diameter ≤ 10 μm
Concentration
0.5-1.5
General Information
Revision date
2026-06-22
Product name
Colorants
1.2.1 Relevant identified uses
Industrial applications
Manufacturer Name
PPG Industries, Inc
Emergency telephone
1-800-441-9695
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H351, H373
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
38.1% (oral), 100% (dermal), 100% (inhalation) This product contains TiO2 which has been classified as a GHS Carcinogen Category 2 based on its IARC 2B classification. For many products, TiO2 is utilized as a raw material in a liquid coating formulation. In this case, the TiO2 particles are bound in a matrix with no meaningful potential for human exposure to unbound particles of TiO2 when the product is applied with a brush or roller. Sanding the coating surface or mist from spray applications may be harmful depending on the duration and level of exposure and require the use of appropriate personal protective equipment and/or engineering controls (see Section 8).
Signal word
Warning
Hazard statements
Causes skin irritation. Causes serious eye irritation. Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. (kidneys)
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection. Do not breathe vapor. Wash thoroughly after handling.
Response
IF exposed or concerned Get medical advice or attention. IF ON SKIN Wash with plenty of water. If skin irritation occurs: Get medical advice or attention. Take off contaminated clothing and wash it before reuse. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Sanding and grinding dusts may be harmful if inhaled. Avoid contact with skin and clothing. Wash thoroughly after handling. Emits toxic fumes when heated.
2.3 Other hazards
Prolonged or repeated contact may dry skin and cause irritation.
2.1 Classification of the substance or mixture
substance or mixture EYE IRRITATION - Category 2A CARCINOGENICITY - Category 2 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 38.1% (oral), 100% (dermal), 100% (inhalation) This product contains TiO2 which has been classified as a GHS Carcinogen Category 2 based on its IARC 2B classification. For many products, TiO2 is utilized as a raw material in a liquid coating formulation. In this case, the TiO2 particles are bound in a matrix with no meaningful potential for human exposure to unbound particles of TiO2 when the product is applied with a brush or roller. Sanding the coating surface or mist from spray applications may be harmful depending on the duration and level of exposure and require the use of appropriate personal protective equipment and/or engineering controls (see Section 8).